Infratil acknowledges Tilt Renewables’ announcement this morning regarding discussions to determine whether it can secure for shareholders a superior scheme arrangement as compared to the scheme of arrangement disclosed to the market on 15 March 2021. Infratil awaits an update from the Company via the NZX/ASX advising an outcome of discussions.
The S&P/ASX 200 has recovered from the US's so-called "Liberation Day".
It will close at the end of July, affecting 120 jobs.
The median price for Cxbladder Triage Plus is US$1,018.44.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details